Skip to content

Non Invasive Brain Stimulation Treatment for CLBP

Unknown statusNot applicableNCT02615418
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

This trial is designed to preliminary evaluate the efficacy and safety of NIBS system for treatment of chronic low back pain (CLBP) (over 6 months). The trial is of a double blind sham controlled partial crossover design and will involve 2 weekly treatments and evaluations for 6 weeks, with 6 weeks follow-up. The goal of the study is to 1. Asses the CLBP change immediate and long term effect for the trial duration and follow-up. 2. Asses quality of life improvement as measure by sleep quality and questioners. 3. Asses long term neuronal changes or lack thereof in treated and untreated subjects.

Study details

Official title
A Novel Non Invasive Brain Stimulation,tDCS Based Treatment for Chronic Low Back Pain (CLBP)-Sourasky Medical Center-Tel Aviv
Interventions
  • Device: NIBS system for evaluation and treatment utilizing non invasive brain stimulation
Sponsor
NIBS NeuroScience Technologies
Start date
2016-01
Primary completion
2017-01
Sex
All
Age range
from 18 Years to 80 Years
Results posted
No results posted in this snapshot
Total sites listed
0

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age 18 to 80 * CLBP as defined by the European guidelines. * low back pain first week average NPRS\>4. Exclusion Criteria: 1. Acute low back pain (duration of less than 6 months) first week average NPRS\> 4 2. Neurological illness causing structural brain damage (e.g. Stroke, TIA) 3. Psychiatric disease other than mood disorders 4. Current chronic use of medications with pro-epileptic properties 5. Known alcohol dependency 6. Use of alcohol within the previous 24 hours 7. History of loss of consciousness 8. Epilepsy or epilepsy in a first degree relative 9. Medical implants 10. Pregnancy 11. Illicit drug use or within the previous month

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02615418